30+ years of clinical research experience across a network of dedicated Research Sites delivering phase Ib-IV clinical trials.
Pratia Germany overview
:quality(70))
Country profile
Germany remains one of Europe's leading destinations for clinical research, combining a highly developed healthcare system, experienced investigators, and access to diverse participant populations.
As part of Pratia's international Research Site Network, Pratia Germany enables Sponsors and CROs to access these advantages through a single operational model, standardized quality processes, and one experienced partner from study start-up through close-out.
Our research sites across Germany
Pratia Germany operates six dedicated research sites, delivering phase Ib-IV clinical trials in a broad range of therapeutic areas.
The sites are strategically located across the country, providing nationwide coverage and convenient access to diverse participant populations while maintaining consistent operational standard
:quality(70))
Berlin
Dedicated outpatient Research Site in the heart of Berlin with overnight capabilities supporting sleep studies and pharmacokinetic assessments. Some of its successes include: influenza vaccine: 173 patients randomized during the 2023/2024 flu season; adiposity: 230 participants randomized in a monocentric trial; irritable bowel syndrome: 50 patients randomized in a DiGA trial.
:quality(70))
Dresden
Located in central Dresden, this research site offers overnight capabilities, PK sampling, and flexible support for phase Ib-IV clinical trials. Named a Top 5 site worldwide after randomizing 22 patients in a sleep apnea trial. Some of its other benchmarks include: influenza vaccine: 161 patients randomized in 2024/2025; sleep apnea: 22 patients randomized, ranking the site among the Top 5 worldwide; dysmenorrhea: 28 participants randomized in a plant-derived medicinal product trial in 2024.
:quality(70))
Hamburg
Dedicated outpatient research site supporting a broad range of studies, including sleep research and pharmacokinetic assessments. Named the best site in Germany in an ongoing ADHD trial, with 45 adult patients randomized. Some of its other benchmarks include: COVID-19: 226 patients randomized within a two-month period for a COVID-19 virus test; major depressive disorder (MDD): 9 patients randomized in a trial involving treatment-resistant severe MDD.
:quality(70))
Hannover
Located in the center of the city, this Research Site offers overnight capabilities and operational flexibility for complex study protocols. Some of its benchmarks include: COVID-19: 225 patients randomized within a two-month period for a COVID-19 virus test; migraine: 24 patients randomized in a 2020 clinical trial; cardiovascular: 51 overweight/obese patients randomized in a cardiovascular study.
:quality(70))
Karlsruhe
Dedicated Research Site providing outpatient clinical research, PK sampling, and overnight study capabilities. Named the best recruiting site in a 2022 dysglycemia trial, with 18 participants randomized. Some of its other benchmarks include: irritable bowel syndrome: 52 patients randomized; sleep apnea: 35 patients randomized, ranking the site among the Top 5 sites worldwide.
:quality(70))
Schwerin
Located in the historic city center, this Research Site offers facilities supporting overnight assessments, sleep studies, and pharmacokinetic sampling. Some of its benchmarks include: lower back pain: 37 participants randomized in 2023/2024 in a CBD versus opioids trial; RSV vaccination: 67 patients assigned to study treatment; cardiovascular: 37 overweight/obese patients randomized in a cardiovascular study
Why choose Pratia Germany?
:quality(70))
"Clinical trials help make the world a better place.
They give people the opportunity to regain their health, live free from symptoms, and help protect future generations from serious diseases."
Therapeutic expertise
Research teams across the Pratia Germany network bring extensive experience across multiple therapeutic areas, with particular expertise in:
Vaccines
Sleep disorders
Pulmonology
Dermatology
Neurology.
:quality(70))
Proven recruitment performance
Dedicated recruitment specialists, multichannel outreach, and established healthcare partnerships accelerate participant recruitment while supporting high retention throughout every study.
:quality(70))
Clinical capacity where your study needs it
Site Service Provision
Pratia Germany provides comprehensive Site Service Provision (SSP), supporting Sponsors, CROs, hospitals, and research sites with experienced clinical research professionals while allowing sites to retain full operational oversight.
Built around the realities of today's clinical research environment, SSP combines experienced Study Coordinators, Study Nurses, Data Entry Specialists, and regulatory expertise with centralized quality oversight and real-time KPI monitoring. Delivered through Pratia's standardized operating model, the service strengthens site capacity, accelerates study start-up, and supports consistent, high-quality trial delivery across Germany and the wider Pratia network.
Our Site Service Provision services include:
Study Coordinators, Study Nurses, and Data Entry Specialists
Site identification and feasibility assessments
Regulatory and Clinical Trial Agreement support
Quality oversight and compliance management
Performance monitoring and KPI reporting
:quality(70))
Active member of BVMA
:quality(70))
Pratia Germany is an active member of the German Association of Contract Research Organizations (BVMA), demonstrating its commitment to high professional standards, regulatory excellence, and the continued advancement of clinical research in Germany.
Meet our team at upcoming industry events
:quality(70))
:quality(70))
:quality(70))
Join Pratia Germany
:quality(70))
Ready to start your clinical trial?
Discover how our flexible approach can support your unique study needs.